- University of Wisconsin School of Medicine and Public Health – MD
- Massachusetts General Hospital, Boston, Massachusetts – Residency in Internal Medicine–Primary Care
- University of Wisconsin School of Medicine and Public Health – Geriatrics Fellowship
- William S. Middleton Memorial Veterans Hospital – Older Women’s Health Fellowship
- University of Wisconsin School of Medicine and Public Health – PhD in Population Health Sciences
Dr. Amy Kind is a faculty member in the Division of Geriatrics and Gerontology within the Department of Medicine. She is the founding director of the Center for Health Disparities Research within the School of Medicine and Public Health and of the Department of Medicine's Health Services and Care Research Program. She also leads the Wisconsin Alzheimer’s Disease Research Center’s (ADRC) Dementia Care Research Core and co-leads the ADRC’s Research Education Core. She has received multiple awards, including the 2020 Wisconsin Medical Alumni Association Early Career Achievement Award and the 2019 American Geriatric Society’s Thomas and Catherine Yoshikawa Award for Outstanding Scientific Achievement for Clinical Investigation. She is a former fellow in the Executive Leadership in Academic Medicine program. Dr. Kind is also a dedicated clinician and serves as an outstanding research mentor, with many successfully funded mentees (National Institutes of Health [NIH] K awards, Diversity supplements).
Dr. Kind currently serves as chair of the Oversight and Advisory Committee of the Wisconsin Partnership Program, the University of Wisconsin School of Medicine and Public Health’s largest endowment-funded grant program. She has also served on numerous national and international advisory boards and committees, including a White House Task Force on Research and Development for Technology to Support Aging Adults and a number of Centers for Medicare and Medicaid (CMS) Technical Expert Panels. She has also previously served as chair of the NIH Clinical Aging study section (NIA-C) and as a consultant to the State of Maryland Department of Health’s Health Services Cost Review Commission, advising on socio-demographic adjustments for hospital-focused policy.
Dr. Kind’s clinical interests include Alzheimer’s disease and related dementias and geriatric transitional care. She maintains an active clinical practice, serving as the director of both the VA Coordinated Transitional Care (C-TraC) Program and the VA Dementia and Cognitive Care Clinic and as an attending physician on the VA Geriatrics Consult Service, all through the Geriatrics Research, Education and Clinical Center (GRECC) of the William S. Middleton Memorial Veterans Hospital.
View Dr. Amy Kind’s publications at NCBI My Bibliography.
Dr. Kind leads a robust research program focused on eliminating health disparities and improving health equity through cutting-edge interdisciplinary research on neighborhood disadvantage, the social determinants of health and Alzheimer’s disease. She and her team developed the Neighborhood Atlas, a free, first-of-its-kind online tool that quantifies socioeconomic disadvantage for every neighborhood in the U.S., including Puerto Rico. Her Atlas data have found widespread application including in the U.S. House of Representatives, NIH, CDC, VA, DOD, HHS, AARP, health systems and industry. Her work has had far-reaching policy impact, has been actively promoted by the NIH and published in top journals including New England Journal of Medicine.
To directly intervene on health disparities, Dr. Kind has successfully designed, implemented, and tested models of care to improve patient outcomes in low resource and safety net areas. Her interventions, such as low-cost models of care to improve coordination of care transitions, have been disseminated widely. Dr. Kind has multiple active R01s from the NIH/National Institute on Minority Health and Health Disparities, the NIH/National Institute on Aging, and routinely advises state, federal and international entities. Her most recent R01 establishes a consortium of 22 Alzheimer’s Disease Research Centers across the US to conduct the largest study of its kind on social determinants of health in the context of AD and to develop a novel collaborative infrastructure of contextual exposure for future social-biological phenotypic evaluation.